0
TG Therapeutics
- 11-50 Employees
- Based in New York City, New York
TG Therapeutics is a biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Currently, the company is developing two therapies targeting hematological malignancies and autoimmune diseases. TG-1101 (ublituximab) is a novel, glycoengineered monoclonal antibody that targets a specific and…More
TG Therapeutics
Most Recent Annual Report
TG Therapeutics does not currently have any hardcopy reports on ²©¾ÅÓéÀÖÍø. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
